Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SiBone (SIBN : NSDQ)

• Company Description    SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California. Number of Employees: 349

• Price / Volume Information    Yesterday's Closing Price: $19.72 Daily Weekly Monthly 20 Day Moving Average: 400,515 shares Shares Outstanding: 43.39 (millions) Market Capitalization: $855.68 (millions) Beta: 0.69 52 Week High: $21.07 52 Week Low: $12.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.49% 2.67% 12 Week 25.44% 23.42% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 471 EL CAMINO REAL SUITE 101 - SANTA CLARA,CA 95050 USA ph: 408-207-0700 fax: - investors@si-bone.com http://si-bone.com

• General Corporate Information    Officers Laura A. Francis - Chief Executive Officer Jeffrey W. Dunn - Chairman Anshul Maheshwari - Chief Financial Officer John G. Freund - Director Jeryl L. Hilleman - Director Peer Information SiBone (ABMD) SiBone (DMDS) SiBone (CPWY.) SiBone (EQUR) SiBone (ECIA) SiBone (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 825704109 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/23/26 Share - Related Items Shares Outstanding: 43.39 Most Recent Split Date: (:1) Beta: 0.69 Market Capitalization: $855.68 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.13 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.47 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/23/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.94 Price/Cash Flow: - Price / Sales: 4.42 EPS Growth vs. Year Ago Period: 31.25% vs. Previous Quarter: 21.43% Sales Growth vs. Year Ago Period: 20.61% vs. Previous Quarter: 0.05% ROE 12/31/25 - - 09/30/25 - -12.86 06/30/25 - -14.20 ROA 12/31/25 - - 09/30/25 - -9.43 06/30/25 - -10.38 Current Ratio 12/31/25 - - 09/30/25 - 7.97 06/30/25 - 8.38 Quick Ratio 12/31/25 - - 09/30/25 - 6.62 06/30/25 - 7.00 Operating Margin 12/31/25 - - 09/30/25 - -11.24 06/30/25 - -12.83 Net Margin 12/31/25 - - 09/30/25 - -11.24 06/30/25 - -12.83 Pre-Tax Margin 12/31/25 - - 09/30/25 - -11.24 06/30/25 - -12.83 Book Value 12/31/25 - - 09/30/25 - 3.99 06/30/25 - 4.00 Inventory Turnover 12/31/25 - - 09/30/25 - 1.24 06/30/25 - 1.30 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.21 06/30/25 - 0.21 Debt-to-Capital 12/31/25 - - 09/30/25 - 17.11 06/30/25 - 17.25

Powered by Zacks Investment Research ©